File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/jmv.20499
- Scopus: eid_2-s2.0-28944441428
- PMID: 16299724
- WOS: WOS:000233738800001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals
Title | Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals |
---|---|
Authors | |
Keywords | Disease progression Neutralizing antibody SARS Vaccine |
Issue Date | 2006 |
Publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/32763 |
Citation | Journal Of Medical Virology, 2006, v. 78 n. 1, p. 1-8 How to Cite? |
Abstract | Most of the SARS-CoV-infected patients spontaneously recovered without clinical intervention while a small percentage succumbed to the disease. Here, we characterized temporal changes in N protein-specific and S glycoprotein-specific neutralizing antibody (Nab) responses in infected patients who have either recovered from or succumbed to SARS-CoV infection. Recovered patients were found to have higher and sustainable levels of both N protein-specific and S glycoprotein-specific Nab responses, suggesting that antibody responses likely play an important role in determining the ultimate disease outcome of SARS-CoV-infected patients. © 2005 Wiley-Liss, Inc. |
Persistent Identifier | http://hdl.handle.net/10722/157427 |
ISSN | 2023 Impact Factor: 6.8 2023 SCImago Journal Rankings: 1.560 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zhang, L | en_US |
dc.contributor.author | Zhang, F | en_US |
dc.contributor.author | Yu, W | en_US |
dc.contributor.author | He, T | en_US |
dc.contributor.author | Yu, J | en_US |
dc.contributor.author | Yi, CE | en_US |
dc.contributor.author | Ba, L | en_US |
dc.contributor.author | Li, W | en_US |
dc.contributor.author | Farzan, M | en_US |
dc.contributor.author | Chen, Z | en_US |
dc.contributor.author | Yuen, KY | en_US |
dc.contributor.author | Ho, D | en_US |
dc.date.accessioned | 2012-08-08T08:49:52Z | - |
dc.date.available | 2012-08-08T08:49:52Z | - |
dc.date.issued | 2006 | en_US |
dc.identifier.citation | Journal Of Medical Virology, 2006, v. 78 n. 1, p. 1-8 | en_US |
dc.identifier.issn | 0146-6615 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/157427 | - |
dc.description.abstract | Most of the SARS-CoV-infected patients spontaneously recovered without clinical intervention while a small percentage succumbed to the disease. Here, we characterized temporal changes in N protein-specific and S glycoprotein-specific neutralizing antibody (Nab) responses in infected patients who have either recovered from or succumbed to SARS-CoV infection. Recovered patients were found to have higher and sustainable levels of both N protein-specific and S glycoprotein-specific Nab responses, suggesting that antibody responses likely play an important role in determining the ultimate disease outcome of SARS-CoV-infected patients. © 2005 Wiley-Liss, Inc. | en_US |
dc.language | eng | en_US |
dc.publisher | John Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/32763 | en_US |
dc.relation.ispartof | Journal of Medical Virology | en_US |
dc.subject | Disease progression | - |
dc.subject | Neutralizing antibody | - |
dc.subject | SARS | - |
dc.subject | Vaccine | - |
dc.subject.mesh | Antibodies, Viral - Blood - Immunology | en_US |
dc.subject.mesh | Disease Progression | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Membrane Glycoproteins - Immunology | en_US |
dc.subject.mesh | Neutralization Tests | en_US |
dc.subject.mesh | Nucleocapsid Proteins - Immunology | en_US |
dc.subject.mesh | Sars Virus - Immunology | en_US |
dc.subject.mesh | Severe Acute Respiratory Syndrome - Immunology - Physiopathology | en_US |
dc.subject.mesh | Viral Envelope Proteins - Immunology | en_US |
dc.title | Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals | en_US |
dc.type | Article | en_US |
dc.identifier.email | Chen, Z:zchenai@hkucc.hku.hk | en_US |
dc.identifier.email | Yuen, KY:kyyuen@hkucc.hku.hk | en_US |
dc.identifier.authority | Chen, Z=rp00243 | en_US |
dc.identifier.authority | Yuen, KY=rp00366 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1002/jmv.20499 | en_US |
dc.identifier.pmid | 16299724 | - |
dc.identifier.scopus | eid_2-s2.0-28944441428 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-28944441428&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 78 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 1 | en_US |
dc.identifier.epage | 8 | en_US |
dc.identifier.isi | WOS:000233738800001 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Zhang, L=8783285300 | en_US |
dc.identifier.scopusauthorid | Zhang, F=10640508100 | en_US |
dc.identifier.scopusauthorid | Yu, W=7403914045 | en_US |
dc.identifier.scopusauthorid | He, T=16935084000 | en_US |
dc.identifier.scopusauthorid | Yu, J=7405525088 | en_US |
dc.identifier.scopusauthorid | Yi, CE=8557032800 | en_US |
dc.identifier.scopusauthorid | Ba, L=8557032300 | en_US |
dc.identifier.scopusauthorid | Li, W=7501793921 | en_US |
dc.identifier.scopusauthorid | Farzan, M=7003535041 | en_US |
dc.identifier.scopusauthorid | Chen, Z=35271180800 | en_US |
dc.identifier.scopusauthorid | Yuen, KY=36078079100 | en_US |
dc.identifier.scopusauthorid | Ho, D=7402971998 | en_US |
dc.identifier.issnl | 0146-6615 | - |